Life Sciences Market Research News ASDReports, Press Releases

AT&T and Kigen Bring SIM Flexibility to Cellular Iot DevicesAT&T and Kigen are working together to help customers streamline their supply chains and reduce the time to market for enterprises who want to leverage SIM, embedded SIM (eSIM) and integrated SIM (iSIM) secured connectivity deep in their IoT devices. Kigen’s SIM OS, data generation and key management services will allow AT&T to offer a broader selection for integrated SIM solutions. Manufacturers will enjoy greater flexibility by sourcing their AT&T SIM at the stage of the d... 17 Sep, 2021
Bausch + Lomb Launches Biotrue(r) Hydration Boost Lubricant Eye Drops and Biotrue(r) Micellar Eyelid Cleansing Wipes New Preservative-Free and pH-Balanced Products Formulated for Irritated, Dry Eyes Now Rolling out to Major U.S. Retailers Bausch + Lomb, a leading global eye health business of Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health"), today announced the U.S. launch of Biotrue® Hydration Boost Lubricant Eye Drops and Biotrue® Micellar Eyelid Cleansing Wipes. Both products are preservative-free and uniquely formulated with naturally inspired ... 10 Sep, 2021
Asensus Surgical Receives FDA 510(k) Clearance for Expansion of Machine Vision CapabilitiesAsensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and patient to pioneer a new era of Performance-Guided Surgery™, today announced that it has received 510(k) clearance from the FDA for an expansion of machine vision capabilities on the previously cleared Intelligent Surgical Unit™ (ISU™). The ISU is utilized with the Company’s Senhance? Surgical System which enables Digital Laparoscopy. “We are thrilled to have rece... 1 Sep, 2021
ENT Devices Market worth $22.3bn by 2026 The growth in this market is attributed to the rising aging population and the associated hearing loss, rise in disposable income and increasing affordability for ENT treatment, improving healthcare infrastructure and expenditure, and rising product availability and awareness. The Hearing Aids segment is expected to grow at the highest CAGR during the forecast period By product, the ENT Devices market is segmented into Diagnostic Devices, Surgical Devices, Hearing Aids, Hearing Implant... 23 Jun, 2021

Life Sciences News